ArticleJournal of the American Geriatrics Society2025
Patterns of Benzodiazepines and Hypnotic Drugs Dispensing After Hip Fracture Among Older US Adults Previously on the Drugs.
Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBenzodiazepines (BZD) and nonbenzodiazepine receptor agonist hypnotics (Z-drugs) strongly increase the risk for hip fractures and should be avoided among older adults with a fall or fracture history. We assessed BZD and Z-drugs refill patterns after discharge for hip fracture among older US adults and explored factors associated with refilling.
methodsWe conducted a retrospective cohort study of US Medicare fee-for-service beneficiaries (20% random sample) aged ≥ 66 years, hospitalized for hip fracture, and discharged home or to a skilled nursing facility. Eligible patients had ≥ 365 days of Medicare Parts A, B, and D coverage and filled a BZD (2013-2019) or Z-drug (2008-2019) ≤ 90 days before hospitalization. We estimated cumulative incidences of refilling the same/increased dose (continuation) and reduced dose (reduction) and their corresponding 95% confidence intervals (CI) within 180 days after discharge, stratified by drug class. We examined demographic factors, comorbidities, and geriatric conditions associated with continuation versus deprescribing (reduction or no refill).
resultsWe included 21,123 eligible patients [11,465 (54%) on short/intermediate-acting BZD, 3473 (16%) on long-acting BZD, and 6185 (29%) on Z-drugs at baseline]. The median age was 82 years; 81% were female and 94% were non-Hispanic White. The continuation within 180 days post discharge was 54.9% (95% CI: 54.0%, 55.8%) for short/intermediate-acting BZD, 58.4% (56.7%, 60.1%) for long-acting BZD, and 56.0% (54.8%, 57.1%) for Z-drugs; 7.2%-16.3% refilled with dose reductions. Younger patients or those with anxiety were at higher risk of continuation.
conclusionsA large proportion of US older adults on BZD or Z-drugs before hospitalization for a hip fracture continued the drugs within 180 days post hospital discharge. This highlights the need for comprehensive medication review and deprescribing intervention during transitions of care in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.